Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results.

Europe’s Pharma Industry Braces for Pain as Trump Tariff Threat Looms

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions drag on.

Lawyer Is Charged With Sadistic Rapes of Women He Met Online

Ryan Hemphill was arraigned Thursday afternoon on a 116-count indictment. Authorities say he tortured, drugged and filmed women in his Midtown apartment.

What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.

Trump Seeks to Lower Drug Prices Through Medicare and Some Imports

President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.

Trump Moves to Put New Tariffs on Computer Chips and Drugs

Citing a national security statute, the administration has begun a process to investigate the impact of imported semiconductors and pharmaceuticals.

Trump’s Tariff Threat for Drug imports Poses Big Political Risks

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.

Stocks Edge Higher as Investors Assess Tariff Scenarios

The Trump administration’s chaotic tariff rollout continues to spur volatility in the markets.